## Session:Real-time Nerve Conduction Velocity (NCV) Interpretation using Machine Learning

* Speaker: Dr. Santosh Kumar Dash
* Designation: Professor & Head, Dept. of Neurology
* Organization: KIMS Bhubaneswar

## 1.1 The Challenge in Peripheral Nerve Diagnostics

A Nerve Conduction Study (NCS), also referred to as a Nerve Conduction Velocity (NCV) test, is a standard diagnostic tool used to assess nerve health and diagnose peripheral neuropathy, a common complication in conditions like diabetes. The test measures the speed and strength of electrical signals traveling through nerves. However, the current process for interpreting the data generated by these studies is fraught with challenges that limit its efficiency and consistency.

Dr. Dash detailed the key difficulties with traditional NCS interpretation:

* Time-Consuming: The manual analysis and reporting process is disproportionately long compared to the test itself. A test that takes only 15 minutes to perform can require 30 to 45 minutes to report.
* Requires Expertise: Accurate interpretation is highly operator-dependent and demands a significant level of clinical skill and experience.
* Inter-Observer Variability: The subjective nature of manual analysis can lead to different conclusions from different clinicians reviewing the same data.
* Increasing Patient Load: The high volume of patients requiring NCS, particularly with the rise of diabetes, creates a bottleneck in clinics and necessitates a more automated solution.

Machine learning presents a promising solution to overcome these workflow inefficiencies and standardize the interpretation process.

## 1.2 A Machine Learning-Powered Workflow for NCV Analysis

The primary goal of applying machine learning to NCV analysis is to create an automated, real-time interpretation system. This moves beyond simple automation to what Dr. Dash terms "augmented intelligence," where technology handles complex data analysis to support and enhance the clinician's diagnostic capabilities.

The proposed workflow for an ML-based system follows a clear, sequential process:

1. Signal Acquisition & Pre-processing: The system first acquires the raw NCV signal, which contains data on latency, amplitude, and velocity. It then cleans the signal by filtering noise, rejecting artifacts, and correcting the baseline to ensure high-quality data.
2. Automated Feature Extraction: A Convolutional Neural Network (CNN) model is used to automatically identify and extract the key diagnostic parameters from the clean signal.
3. Intelligent Interpretation & Classification: The model provides an instantaneous classification of the results. It predicts whether the test is normal or abnormal and can further identify the specific type of nerve damage (e.g., axonal vs. demyelinating).
4. Real-Time Report Generation & Validation: The final step is the immediate generation of a comprehensive report, which is then ready for final validation by a physician.

This automated workflow offers a dramatic improvement over the traditional manual process, primarily in speed and consistency.

* Traditional Manual Reporting	AI-Based Reporting
* 30-45 minutes to generate a report	< 1 minute to generate a report
* Prone to inter-observer variability	Highly consistent and reproducible results

The theoretical advantages of this workflow are now being validated by real-world evidence from cutting-edge AI models.

## 1.3 Case Study: The "inspire" Multimodal AI Model

* Dr. Dash presented the "inspire" model, detailed in a recent 2023 publication, as a state-of-the-art example of AI in neurodiagnostics. Its key innovation lies in its multimodal approach, which represents a significant leap beyond older, single-focus models.

* Unlike traditional AI systems that analyzed only the numerical data from the NCV test, the "inspire" model integrates the patient's clinical context, including their symptoms and medical history. This more holistic analysis led to a substantial increase in diagnostic accuracy, achieving approximately 92% accuracy in distinguishing between normal and abnormal test results.

* To provide clinicians with a transparent measure of the AI's confidence, the system incorporates the iigers Score (AI-generated EMG report score). This composite score serves as a standardized quality metric. A high score (e.g., 90-100) indicates a 'report ready' result with high confidence, while a low score (<60) signals that the AI's output may be unreliable, prompting the clinician to perform a manual review or repeat the test.

* The model's high accuracy was further validated in a randomized controlled trial (RCT) that compared its performance against physician-only interpretation. The "inspire" model exemplifies the field's shift towards more sophisticated, context-aware AI that can more closely mirror the diagnostic process of a human expert.

## 1.4 Future Directions, Limitations, and Final Perspective

While current models like "inspire" are impressive, the future of AI in neurophysiology holds even greater potential. Dr. Dash outlined several promising future directions:

* Real-time Procedural Guidance: AI could provide live feedback to technicians during an NCV test, helping them optimize electrode placement and stimulus intensity to ensure the capture of high-quality waveforms.
* Multimodal Integration: The technology could combine NCV data with other diagnostic inputs, such as neuromuscular ultrasound images, to create a more comprehensive and holistic assessment of nerve health.
* Predictive Phenotyping: AI may be able to analyze patterns in NCV data to prognosticate patient outcomes, predicting whether a patient's condition is likely to improve or decline over time.

However, these future advancements must be pursued with an awareness of the inherent limitations, including the risk of automation bias (over-reliance on the AI's output), technical challenges with data quality, and ethical considerations regarding report accuracy and the necessity of human validation.

In closing, Dr. Dash offered a powerful perspective that encapsulates the overarching theme from both presentations. The ultimate goal is not to replace the clinician but to empower them with advanced tools.

The goal is augmented intelligence. The most successful clinical environments will treat the AI model as a highly skilled digital resident, capable of doing the heavy lifting but requiring the seasoned oversight of a human expert.
